The momentum is changing! Nationwide comprehensive research studies in the area of genetics of familial pancreatic cancer and pancreatitis have discovered several answers leading to preventive treatments and cures for pancreatic disease. Advances in pain management are critical to an enhanced life style for patients. More information and the grant application is available in the grants and awards section.

The following articles are reprinted courtesy of the University of Texas MD Anderson Cancer Center who recently sponsored a conference on Multidisciplinary Treatment of Pancreas, Liver and Biliary Tract Cancer.

Endoscopic Ultrasound in Pancreatic adenocarcinoma
Richard A. Erickson, M.D., FACP, FACG
Director, Division of Gastroenterology
Scott & White Clinic and Hospital
Professor of Medicine
Department of Medicine,
Texas A&M University Health Science Center

Preoperative Evaluation in Pancreatic Cancer- How much is enough?
Mark P. Callery, MD, FACS
Associate Professor of Surgery
Harvard Medical School
Chief, Division of General Surgery
Beth Israel Deaconess Medical Center
Boston, Massachusetts USA

BORDERLINE RESECTABLE PANCREATIC CANCER
Douglas B. Evans, M.D.
For the Multidisciplinary Pancreatic Tumor Study Group
Departments of Surgical Oncology,
The University of Texas M. D. Anderson Cancer Center,
Houston, Texas

CLINICAL MANAGEMENT OF INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS OF THE PANCREAS
Carlos Fernández-del Castillo, M.D.
Associate Professor of Surgery
Massachusetts General Hospital
Harvard Medical School, Boston, MA